[사회]58,000 Pfizers arrived in Korea today…1st vaccination completed in March

[앵커]

58,000 Pfizer vaccines, which will be targeted by medical staff treating corona19 patients, are coming into Korea today.

We plan to start vaccination this weekend and complete the first vaccination in March.

Reporter Park Hong-gu on the report.

[기자]

Pfizer’s supply from Cobax Facility, an international vaccine joint purchase project, arrives in Korea by air.

Vaccines for 58,000 people are divided at the airport and delivered to 5 vaccination centers first, and then transferred to 82 in-house vaccination centers.

The first vaccination will take place at the Central Vaccination Center at 9 am on the 27th and target 300 people, including workers at the National Medical Center.

Other regions will be vaccinated on the 3rd of the following month after training on how to store and thaw Pfizer vaccines and how to dilute injections.

[정경실 / 코로나19 예방접종대응추진단 예방접종관리반장 : 우선적으로는 중앙접종센터에서 접종을 시행하면서 권역의 예방접종센터의 접종인력들 그리고 감염병 전담병원의 의료진들이 나와서 참관하고 교육을 받는 시간이 필요합니다.]

Pfizer’s vaccine, which is a two-time vaccination, will be administered by the 20th of the following month, and the second vaccination will be given 3 weeks later.

While working at the same hospital dedicated to Corona 19, there was controversy over the issue of getting a different vaccine.

Pfizer’s medical staff in charge of patient care are controversial over the equity of getting the AstraZeneca vaccine for general ward workers.

In response, the Korea Centers for Disease Control and Prevention (KCDC) asked for understanding that it took into account the high risk of infection for the treatment staff of COVID-19 patients, although vaccines could not be discussed superior or inferior depending on the type.

[정경실 / 코로나19 예방접종대응추진단 예방접종관리반장 : 이 백신은 감염에 노출될 우려가 크고, 또 의료와 방역체계 유지에 긴급한 필요성이 있는 감염병 전담병원의 의료진에게 배정하였습니다.]

Apart from the quantity of CoVax, a verification procedure was also conducted to introduce a vaccine that Pfizer directly receives.

The Ministry of Food and Drug Safety opened the Central Pharmaceutical Affairs Commission, a legal review body, and sought expert advice on the safety and effectiveness of Pfizer vaccines and considerations for approval.

This is YTN Park Hong-gu.

※’Your report becomes news’ YTN awaits your valuable report.
[카카오톡] Search YTN to add a channel [전화] 02-398-8585 [메일] [email protected] [온라인 제보] www.ytn.co.kr

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]

– .